Patent details

EP3392266 Title: LINACLOTIDE SYNTHESIS METHOD

Basic Information

Publication number:
EP3392266
PCT Application Number:
CN2016110106
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP168748671
PCT Publication Number:
WO2017101810
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
LINACLOTIDE SYNTHESIS METHOD
French Title of Invention:
PROCÉDÉ DE SYNTHÈSE DE LINACLOTIDE
German Title of Invention:
LINACLOTIDSYNTHESEVERFAHREN
SPC Number:

Dates

Filing date:
15/12/2016
Grant date:
27/05/2020
EP Publication Date:
24/10/2018
PCT Publication Date:
22/06/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
27/05/2020
EP B1 Publication Date:
27/05/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
15/12/2020
Expiration date:
15/12/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/05/2020
 
 

Name:
Hybio Pharmaceutical Co., Ltd.
Address:
4th Floor Office Building, Hybio Medicine Park, Hi-Tech Industrial Park Central, Nanshan District, Shenzhen, Guangdong 518057, China (CN)

Inventor

1

Name:
WU, Jingkang
Address:
China (CN)

2

Name:
TAO, Anjin
Address:
China (CN)

3

Name:
MI, Pengcheng
Address:
China (CN)

4

Name:
YUAN, Jiancheng
Address:
China (CN)

5

Name:
CHEN, Xueming
Address:
China (CN)

Priority

Priority Number:
201510964573
Priority Date:
18/12/2015
Priority Country:
China (CN)

Classification

IPC classification:
C07K 1/06; C07K 7/08;

Publication

European Patent Bulletin

Issue number:
202022
Publication date:
27/05/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages